AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Kalkine: Cochlear Launches Smart Implant System as ASX 200 Healthcare Stock Updates FY25 Outlook
June 12, 2025 02:06 PM AEST| By Team Kalkine MediaHighlights,Cochlear Ltd (ASX:COH) introduces Nucleus Nexa System with firmware upgrade functionality,FY25 earnings guidance revised amid slower Services segment performance,Cochlear Ltd (ASX:COH), a key healthcare stock listed on the,ASX 200,,,ASX 10...
Kalkine: Monash IVF (ASX:MVF) Faces Leadership Shakeup Amid Embryo Error Incidents
June 12, 2025 01:50 PM AEST| By Team Kalkine MediaHighlights,CEO steps down following back-to-back embryo mix-ups,Acting CEO appointed as company reassures financial outlook,Renewed calls for national IVF regulation intensify,Monash IVF Group Ltd (ASX:MVF), a member of the ASX300, is under the spotl...
Kalkine: Monash IVF (ASX:MVF) Rises as CEO Steps Down Amid Second Embryo Mix-Up
June 12, 2025 01:46 PM AEST| By Team Kalkine MediaHighlights,Monash IVF CEO exits following second embryo transfer error,Shares surge,nearly 8%,after leadership change,Public demand rises for national IVF regulation,Shares of fertility services provider Monash IVF (ASX:MVF) surged following the resi...
Kalkine: Cochlear (ASX:COH) Shares Stabilise Amid Guidance Update and Product Launch in ASX300
June 12, 2025 12:34 PM AEST| By Team Kalkine MediaHighlights,Cochlear updates FY guidance; stock recovers early losses,New product launch aims to lift future revenue streams,ASX300 spotlight: Innovation counters market slowdown,Cochlear (ASX:COH), a key player in the hearing implant space and a cons...
Kalkine: Cettire (ASX:CTT) Shares Plunge Amid Weak Trading Update; ASX300 Firm Faces Steep Cash Burn
June 12, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights,Cettire's,Q4 performance fell short of EBITDA expectations,Revenue and cash levels declined sharply in April and May,Concerns grow over potential equity raise to restore capital buffer,Luxury online fashion retailer,Cettire (ASX:CTT),saw a...
Kalkine : ASX 200 Stock Monash IVF Rebounds After Embryo Mix-Up Concerns
June 11, 2025 05:37 PM AEST| By Team Kalkine MediaHighlights,Monash IVF shares regain ground after a sharp decline on Tuesday,Macquarie labels the share price fall as an overreaction,Ongoing support for IVF sector expected despite operational errors,Monash IVF Group Ltd (ASX:MVF), listed on the,ASX...
Kalkine: ASX 200 Biotech Stock CU6 Surges on Promising Trial Data
June 11, 2025 04:17 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals Ltd (ASX:CU6) reported successful Phase II trial results for neuroendocrine tumour diagnostics,Company advancing targeted copper theranostics for cancer using SAR Technology Platform,ASX 200 index gains amid renewed...
Kalkine: Noxopharm's Sofra™ Platform Gains Momentum with BioRay Study in ASX300 Biotech Space
June 11, 2025 03:30 PM AEST| By Team Kalkine MediaHighlights,Noxopharm’s Sofra™ tech validated through BioRay testing,Promising inflammation-fighting results from oligonucleotide platform,Collaboration boosts Sofra’s potential as versatile ASX300 biotech innovation,Noxopharm Limited (ASX:NOX), a cli...
Kalkine: PME Shares Surge in ASX200: Exploring Growth, Tech & Ethical Edge in Healthcare
June 11, 2025 03:20 PM AEST| By Team Kalkine MediaHighlights,PME shares have risen over 12% YTD amid healthcare sector momentum,Visage technology positions Pro Medicus as a global leader in radiology software,Ethical and growth-focused exposure within the ASX200 healthcare ecosystem,The healthcare s...
Kalkine: Cyclopharm Gets Technegas Patent Extension, Boosting ASX200 Growth Story
June 11, 2025 01:57 PM AEST| By Team Kalkine MediaHighlights,Cyclopharm,secures US patent extension for,Technegas,to 2031,Strengthens exclusivity in world’s largest healthcare market,Bolsters,commercialisation,pathway in lung imaging space,Cyclopharm (ASX:CYC) has achieved a critical milestone in it...
Kalkine: Prescient Therapeutics Leads ASX200 Biotech Push With Innovations in Cancer Therapy (ASX:PTX)
June 11, 2025 11:19 AM AEST| By Team Kalkine MediaHighlights,PTX-100 targets high-mortality cancers linked to RAS mutations.,Prescient’s,cell therapies aim to enhance CAR-T effectiveness.,Fast-track designations support regulatory progress.,Prescient Therapeutics (ASX:PTX), a clinical-stage biotechn...
Kalkine: ASX 200 Eyes Innovation as Lyrebird Health Secures New Capital for AI Scribe Tool
June 10, 2025 03:22 PM AEST| By Team Kalkine MediaHighlights,Lyrebird Health completes funding round to strengthen AI-based clinical documentation platform,Backing from Five V Capital and Octopus Ventures supports global scale-up and regulatory compliance,Integration efforts continue with electronic...
Kalkine: Botanix (ASX:BOT) Strengthens Commercial Push with A$48M Facility Backing in ASX200 Spotlight
June 10, 2025 02:40 PM AEST| By Team Kalkine MediaHighlights,Botanix secures A$48M debt facility to fuel commercial rollout,Capital directed toward Sofdra™ launch and platform growth,Strategic financial moves bolster Botanix’s ASX200 presence,Botanix Pharmaceuticals Ltd (ASX:BOT), a clinical-stage p...
Kalkine: ASX 200 Watch: INOVIQ (ASX:IIQ) Updates on Cash Position Amid Sector Pressures
June 10, 2025 02:26 PM AEST| By Team Kalkine MediaHighlights,INOVIQ (ASX:IIQ) operates within the biotech sector, focusing on diagnostics and clinical development technologies,Company outlines updated cash position and reduced outflows over the past financial year,Sector sentiment influenced by broa...
Kalkine: EZZ Life Science Secures $21M South-East Asia Deal, Boosting ASX200 Exposure
June 10, 2025 02:21 PM AEST| By Team Kalkine MediaHighlights,EZZ inks $21 million South-East Asia deal,ROFA to distribute across Thailand, Vietnam, Singapore,US manufacturing to strengthen global presence,EZZ Life Science Holdings (ASX:EZZ) has taken a significant leap forward in its international e...
Kalkine: Monash IVF Faces Second Embryo Error in 2025, Stirring ASX200 Concerns
June 10, 2025 01:05 PM AEST| By Team Kalkine MediaHighlights,Monash IVF (MVF) reported a second embryo transfer error this year.,The company is introducing stricter verification and oversight.,MVF,remains,part of broader conversations in the ASX200 healthcare sector.,Shares of Monash IVF Group Ltd (...
Kalkine: Leadership Reshuffle at Anteris (ASX:AVR) Highlights Strategic Growth Amid ASX200 Momentum
June 10, 2025 12:09 PM AEST| By Team Kalkine MediaHighlights,Anteris,adds two independent directors to its board.,Governance reshuffle supports,pivotal,clinical phase.,Strong alignment with shareholder interests through equity-linked compensation.,Anteris Technologies (ASX:AVR), a developer of trans...
Kalkine: Future Fund Legal Chief Joins CSL Board Amid ASX200 Leadership Moves
June 10, 2025 10:38 AM AEST| By Team Kalkine MediaHighlights,Cameron Price to join CSL board as non-executive director,Transition follows over a decade of strategic leadership at Future Fund,CSL bolsters governance amid dynamic ASX200 market shifts,CSL Limited (ASX:CSL), one of the leading biotech g...
Kalkine: Leadership Change at Integral Diagnostics (ASX:IDX) as CEO Sets Retirement Timeline | ASX200 Update
June 06, 2025 05:07 PM AEST| By Team Kalkine MediaHighlights,Integral Diagnostics (IDX) CEO to retire by FY26-end,Leadership transition aligned with recent Capitol Health merger,New CEO search underway amid ASX200 index presence,Integral Diagnostics (ASX:IDX), a key player in the medical imaging spa...
Kalkine: Imugene Advances Cancer Pipeline with New Trial Milestones and CMO Leadership
June 06, 2025 01:43 PM AEST| By Team Kalkine MediaHighlights,Imugene Ltd (ASX:IMU, OTC:IUGNF) initiates Phase 2 trials for PD1-Vaxx in Australia,New CMO Dr John Byon focuses on durable responses in advanced therapies,Expansion into rare blood cancers and strategic development for onCARlytics continu...
Advertise your brand on Kalkine Media